Loading...
XJPX4118
Market cap1.45bUSD
Jan 17, Last price  
3,610.00JPY
1D
0.36%
1Q
-5.02%
Jan 2017
-24.16%
Name

Kaneka Corp

Chart & Performance

D1W1MN
XJPX:4118 chart
P/E
9.78
P/S
0.30
EPS
368.96
Div Yield, %
3.14%
Shrs. gr., 5y
-0.19%
Rev. gr., 5y
4.18%
Revenues
762.30b
+0.86%
438,000,000,000464,310,000,000473,170,000,000502,968,000,000449,585,000,000412,490,000,000453,826,000,000469,289,000,000476,462,000,000524,785,000,000552,189,000,000555,227,000,000548,222,000,000596,142,000,000621,043,000,000601,514,000,000577,426,000,000691,530,000,000755,821,000,000762,302,000,000
Net income
23.22b
+0.92%
24,745,000,00028,099,000,00018,363,000,00018,817,000,000-1,850,000,0008,406,000,00011,625,000,0005,402,000,0009,325,000,00013,650,000,00018,033,000,00020,985,000,00020,484,000,00021,571,000,00022,238,000,00014,003,000,00015,831,000,00026,487,000,00023,008,000,00023,220,000,000
CFO
61.91b
+115.64%
43,242,000,00047,402,000,00032,742,000,00039,418,000,00026,464,000,00057,412,000,00034,932,000,00015,842,000,00032,775,000,00033,924,000,00033,602,000,00059,704,000,00048,119,000,00049,750,000,00041,113,000,00039,983,000,00074,040,000,00034,106,000,00028,710,000,00061,911,000,000
Dividend
Mar 28, 20250 JPY/sh
Earnings
Feb 06, 2025

Profile

Kaneka Corporation manufactures and sells polyvinyl chloride (PVC), crosslinked PVC, PVC-PVAc polymers, paste PVC, acryl grafted-vinyl chloride copolymer, and chlorinated PVC in Japan and internationally. It provides impact modifiers, processing aids, specialty additives, toughener for thermosetting resins, silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, and biodegradable polymer, engineering resin for injection molding, zero birefringence, acrylic film, and isobutylene-based thermoplastic elastomer products. The company also offers polypropylene and kanelite foams, extruded polystyrene foam insulation, polyimide film, transparent film for optical use, high thermal conductive graphite sheets, multi-layer insulation, transparent conductive film, and thermo-resistant, and light-resistant transparent resin products. In addition, it provides photovoltaic power generation systems for residences, public, and industrial installations; eco fur, flame-retardant, hair accessory, and new materials; organic EL lighting panels; and biosurfactant. Further, the company offers intervention, blood purification, gastroenterology intervention, testing equipment, regenerative medicine and cell therapy, and genetic diagnostic products; and low molecular pharmaceutical materials, affinity chromatography resin for purification of a monoclonal antibody, biopharmaceuticals, transdermal medicine, and innerwear with shock-absorbing pad. It also provides dairy products, margarine, fat and oils, whipping cream, filling, baker's yeast/ dough improver, processed fruits, butter, shortening, cacao butter alternatives, cream for kneading and other uses, frozen dough, spices, antifreeze materials; and pharma and supplemental nutrition solutions, including coenzyme, lactic-acid bacteria, and functional foodstuffs, as well as fertilizers. Kaneka Corporation was incorporated in 1949 and is headquartered in Tokyo, Japan.
URL
https://www.kaneka.co.jp/
IPO date
Oct 31, 1949
Employees
11,545
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
762,302,000
0.86%
755,821,000
9.30%
691,530,000
19.76%
Cost of revenue
721,882,000
713,424,000
641,748,000
Unusual Expense (Income)
NOPBT
40,420,000
42,397,000
49,782,000
NOPBT Margin
5.30%
5.61%
7.20%
Operating Taxes
12,033,000
8,298,000
8,676,000
Tax Rate
29.77%
19.57%
17.43%
NOPAT
28,387,000
34,099,000
41,106,000
Net income
23,220,000
0.92%
23,008,000
-13.13%
26,487,000
67.31%
Dividends
(7,139,000)
(7,599,000)
(6,523,000)
Dividend yield
2.88%
3.34%
2.81%
Proceeds from repurchase of equity
(2,814,000)
(8,051,000)
14,872,000
BB yield
1.13%
3.54%
-6.42%
Debt
Debt current
122,472,000
117,528,000
89,992,000
Long-term debt
90,795,000
74,161,000
42,837,000
Deferred revenue
7,000
23,204,000
34,185,000
Other long-term liabilities
22,042,000
4,655,000
5,424,000
Net debt
98,389,000
77,998,000
21,245,000
Cash flow
Cash from operating activities
61,911,000
28,710,000
34,106,000
CAPEX
(65,266,000)
(41,991,000)
(39,930,000)
Cash from investing activities
(58,771,000)
(41,970,000)
(39,595,000)
Cash from financing activities
(1,519,000)
12,352,000
(1,105,000)
FCF
(56,806,000)
15,035,000
(4,472,000)
Balance
Cash
43,969,000
41,868,000
41,952,000
Long term investments
70,909,000
71,823,000
69,632,000
Excess cash
76,762,900
75,899,950
77,007,500
Stockholders' equity
452,005,000
792,678,000
754,756,000
Invested Capital
614,755,100
518,416,050
499,285,500
ROIC
5.01%
6.70%
8.71%
ROCE
5.77%
7.11%
8.61%
EV
Common stock shares outstanding
65,066
65,990
65,391
Price
3,814.00
10.55%
3,450.00
-2.68%
3,545.00
-22.09%
Market cap
248,161,724
9.00%
227,665,497
-1.79%
231,811,095
-22.05%
EV
366,821,724
701,187,497
639,907,095
EBITDA
81,199,000
81,853,000
87,735,000
EV/EBITDA
4.52
8.57
7.29
Interest
3,361,000
1,965,000
1,064,000
Interest/NOPBT
8.32%
4.63%
2.14%